COVID-19 Vaccine: ‘No Nigerian Has So Far Developed Severe Side Effects’ – NPHCDA
Nigeria received its first batch of the AstraZeneca COVID-19 vaccine on March 2 and over 8,000 people have since been vaccinated across 35 states and Federal Capital Territory (FCT).
There have been reports on the development of blood clots in some recipients of the vaccine, causing several European countries to discontinue its use.
NPHCDA, however, assured Nigerians on the safety of the doses, stating that there is evidence showing that the vaccine does not cause blood clots and that the batch supplied to the country is safe.
In a tweet on Monday, NPHCDA noted that no one who has received the shot in Nigeria has so far presented any “severe side effects”.
It, however, did not state if mild effects have been reported.
The tweet reads;
FACT: No Nigerian so far has developed any known severe side effects following vaccination with AstraZeneca vaccine.
— NPHCDA (@NphcdaNG) March 22, 2021